AstraZeneca and University of Michigan partner to advance treatments for CKD

AstraZeneca has entered a two-year research collaboration with the University of Michigan to advance treatments for chronic kidney disease (CKD).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news